Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Orthopedics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Bone Miner Res. 2021 Feb;36(2):271-282. doi: 10.1002/jbmr.4197. Epub 2020 Nov 12.
Reduced bone mineral density (BMD; ie, Z-score ≤-2.0) occurring at a young age (ie, premenopausal women and men <50 years) in the absence of secondary osteoporosis is considered early-onset osteoporosis (EOOP). Mutations affecting the WNT signaling pathway are of special interest because of their key role in bone mass regulation. Here, we analyzed the effects of relevant LRP5 and LRP6 variants on the clinical phenotype, bone turnover, BMD, and bone microarchitecture. After exclusion of secondary osteoporosis, EOOP patients (n = 372) were genotyped by gene panel sequencing, and segregation analysis of variants in LRP5/LRP6 was performed. The clinical assessment included the evaluation of bone turnover parameters, BMD by dual-energy X-ray absorptiometry, and microarchitecture via high-resolution peripheral quantitative computed tomography (HR-pQCT). In 50 individuals (31 EOOP index patients, 19 family members), relevant variants affecting LRP5 or LRP6 were detected (42 LRP5 and 8 LRP6 variants), including 10 novel variants. Seventeen variants were classified as disease causing, 14 were variants of unknown significance, and 19 were BMD-associated single-nucleotide polymorphisms (SNPs). One patient harbored compound heterozygous LRP5 mutations causing osteoporosis-pseudoglioma syndrome. Fractures were reported in 37 of 50 individuals, consisting of vertebral (18 of 50) and peripheral (29 of 50) fractures. Low bone formation was revealed in all individuals. A Z-score ≤-2.0 was detected in 31 of 50 individuals, and values at the spine were significantly lower than those at the hip (-2.1 ± 1.3 versus -1.6 ± 0.8; p = .003). HR-pQCT analysis (n = 34) showed impaired microarchitecture in trabecular and cortical compartments. Significant differences regarding the clinical phenotype were detectable between index patients and family members but not between different variant classes. Relevant variants in LRP5 and LRP6 contribute to EOOP in a substantial number of individuals, leading to a high number of fractures, low bone formation, reduced Z-scores, and impaired microarchitecture. This detailed skeletal characterization improves the interpretation of known and novel LRP5 and LRP6 variants. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
(骨)矿物质密度降低(BMD;即 Z 评分≤-2.0),且发生于年轻时期(即绝经前女性和<50 岁男性),无继发性骨质疏松症,被认为是早发性骨质疏松症(EOOP)。影响 WNT 信号通路的突变尤其受到关注,因为它们在骨量调节中起着关键作用。在此,我们分析了相关 LRP5 和 LRP6 变体对临床表型、骨转换、BMD 和骨微结构的影响。在排除继发性骨质疏松症后,通过基因面板测序对 EOOP 患者(n=372)进行基因分型,并对 LRP5/LRP6 中的变体进行分离分析。临床评估包括评估骨转换参数、双能 X 射线吸收法测定的 BMD 和高分辨率外周定量计算机断层扫描(HR-pQCT)测定的微结构。在 50 个人(31 名 EOOP 索引患者,19 名家族成员)中,检测到影响 LRP5 或 LRP6 的相关变体(42 个 LRP5 和 8 个 LRP6 变体),包括 10 个新变体。17 个变体被归类为致病变体,14 个为意义不明的变体,19 个为与 BMD 相关的单核苷酸多态性(SNP)。一名患者携带导致骨质疏松-假瘤综合征的复合杂合性 LRP5 突变。50 个人中有 37 人报告了骨折,包括椎体(50 人中有 18 人)和外周(50 人中有 29 人)骨折。所有个体均显示低骨形成。50 人中有 31 人 Z 评分≤-2.0,脊柱的 Z 评分明显低于髋部(-2.1±1.3 比-1.6±0.8;p=0.003)。HR-pQCT 分析(n=34)显示在小梁和皮质区存在受损的微结构。索引患者和家族成员之间可检测到临床表型的显著差异,但不同变体类别之间没有差异。LRP5 和 LRP6 中的相关变体在大量个体中导致 EOOP,导致大量骨折、低骨形成、降低的 Z 评分和受损的微结构。这种详细的骨骼特征可改善对已知和新型 LRP5 和 LRP6 变体的解释。 © 2020 美国骨骼与矿物质研究协会(ASBMR) Wiley 期刊出版公司代表《骨与矿物质研究杂志》发表。